Article

Optimization of NLS Composition Improves CRISPR-Cas12a Editing Rates in Human Primary Cells

2022-02-01

Abstract excerpt

Type V CRISPR–Cas12a systems are an attractive alternative nuclease platform for specific genome editing applications. However, previous studies demonstrate that there is a gap in overall activity between Cas12a and Cas9 in primary cells. Here we describe optimization to the nuclear localization signal composition and architecture of Cas12a to facilitate highly efficient targeted mutagenesis in mammalian cell line...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9586c599-5e94-5b52-b3ab-701c4c9c4ae8
DOI: 10.1101/2022.02.01.478672

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optimization of NLS Composition Improves CRISPR-Cas12a Editing Rates in Human Primary CellsDOI 10.1101/2022.02.01.478672Read

Optimization of Nuclear Localization Signal Composition Improves CRISPR-Cas12a Editing Rates in Human Primary CellsSemantic proximity Read

AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicinesSemantic proximity Read

A robust platform for expansion and genome editing of primary human natural killer cellsSemantic proximity Read

Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 RibonucleoproteinsSemantic proximity Read

Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9Semantic proximity Read

CRISPR-Targeted CAR Gene Insertion Using Cas9/RNP and AAV6 Enhances Anti-AML Activity of Primary NK CellsSemantic proximity Read

Boosting genome editing efficiency in human cells and plants with novel LbCas12a variantsSemantic proximity Read

Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAVSemantic proximity Read

Optimization of AsCas12a for combinatorial genetic screens in human cellsSemantic proximity Read

Viral delivery of compact CRISPR-Cas12f for <i>in vivo</i> gene editing applicationsSemantic proximity Read

A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapySemantic proximity Read

Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cellsSemantic proximity Read